Browse by Title

75 items found

Showing titles from 25 to 50:

  1  2  3   
FormatDateTitleAuthor
FormatDateTitleAuthor
out url icon Recercat A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation Castro Gallegos, Jessica ; Ribó i Panosa, Marc ; Navarro, Susanna ; Nogués, Maria Victòria ; Vilanova i Brugués, Maria ; Benito i Mundet, Antoni
out url icon Recercat 2018 June 1 A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation
out url icon Recercat 2018 June 5 A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation Castro Gallegos, Jessica ; Ribó i Panosa, Marc ; Navarro, Susanna ; Nogués, Maria Victòria ; Vilanova i Brugués, Maria ; Benito i Mundet, Antoni
doc icon DUGiDocs 2016 November Impact of BRCA1/2 somatic mutations in patients with pancreatic cancer in Girona: a population-based study Huarachi Berne, Nadia
out url icon Recercat Impact of BRCA1/2 somatic mutations in patients with pancreatic cancer in Girona: a population-based study García Velasco, Adelaida ; Huarachi Berne, Nadia
doc icon DUGiDocs 2017 January Intracorporeal vs. extracorporeal anastomosis in laparoscopic right hemicolectomy for cancer Aramburu Munoa, Alba
out url icon Recercat Intracorporeal vs. extracorporeal anastomosis in laparoscopic right hemicolectomy for cancer Aramburu Munoa, Alba
doc icon DUGiDocs 2012 April Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
out url icon Recercat Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
out url icon Recercat Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
out url icon Recercat 2018 June 1 Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
out url icon Recercat 2018 June 5 Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2011 A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines Puig i Miquel, Teresa ; Aguilar, Helena ; Cufí González, Sílvia ; Oliveras, Glòria ; Turrado, Carlos ; Ortega Gutiérrez, Sílvia ; Benhamú, Bellinda ; López Rodríguez, Maria Luz ; Urruticoechea, Ander ; Colomer, Ramon
out url icon Recercat A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines Puig i Miquel, Teresa ; Aguilar, Helena ; Cufí González, Sílvia ; Oliveras, Glòria ; Turrado, Carlos ; Ortega Gutiérrez, Sílvia ; Benhamú, Bellinda ; López Rodríguez, Maria Luz ; Urruticoechea, Ander ; Colomer, Ramon
out url icon Recercat A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines Puig i Miquel, Teresa ; Aguilar, Helena ; Cufí González, Sílvia ; Oliveras, Glòria ; Turrado, Carlos ; Ortega Gutiérrez, Sílvia ; Benhamú, Bellinda ; López Rodríguez, Maria Luz ; Urruticoechea, Ander ; Colomer, Ramon
out url icon Recercat 2018 June 1 A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines
out url icon Recercat 2018 June 5 A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines Puig i Miquel, Teresa ; Aguilar, Helena ; Cufí González, Sílvia ; Oliveras, Glòria ; Turrado, Carlos ; Ortega Gutiérrez, Sílvia ; Benhamú, Bellinda ; López Rodríguez, Maria Luz ; Urruticoechea, Ander ; Colomer, Ramon
doc icon DUGiDocs 2016 A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells Vert Company, Anna ; Castro Gallegos, Jessica ; Ribó i Panosa, Marc ; Benito i Mundet, Antoni ; Vilanova i Brugués, Maria
out url icon Recercat A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells Vert Company, Anna ; Castro Gallegos, Jessica ; Ribó i Panosa, Marc ; Benito i Mundet, Antoni ; Vilanova i Brugués, Maria
out url icon Recercat A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells Vert Company, Anna ; Castro Gallegos, Jessica ; Ribó i Panosa, Marc ; Benito i Mundet, Antoni ; Vilanova i Brugués, Maria
out url icon Recercat 2018 June 1 A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells
out url icon Recercat 2018 June 5 A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells Vert Company, Anna ; Castro Gallegos, Jessica ; Ribó i Panosa, Marc ; Benito i Mundet, Antoni ; Vilanova i Brugués, Maria
doc icon DUGiDocs 2015 Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
out url icon Recercat Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
out url icon Recercat Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
  1  2  3   

Subjects

Authors